ORPHA:402035
Eosinophilic colitis
Publications
1,108
Trials
0
Interventional, condition-specific
Researchers
1,151
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare gastroenterologic disease characterized by extensive eosinophilic infiltration of the colon in the absence of any known cause of secondary intestinal eosinophilia. Patients present with abdominal pain, nausea, vomiting, diarrhea, gastrointestinal bleeding, malabsorption, and/or weight loss. Symptoms do not correlate with the extent of the disease, which can be segmental or pancolonic. Blood testing may show peripheral eosinophilia. The condition has a bimodal age distribution, with a first peak in neonates and a second peak in young adulthood.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0018439
- UMLS:C0267448
- NCIT:C27053
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
1,108 matched papers (705 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPartial
None under the specific name; 1275 for broader category colitis
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
1,108
1,108 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
1,108 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
705 in the last 10 years · low confidence
Phrase hits: 1,108 · MeSH hits: 0
Who's working on it?
1,151
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Dellon ES12 papers · 2026
Center for Gastrointestinal Biology and Disease, University of North Carolina School of Medicine, Chapel Hill, NC, USA; Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA. Electronic address: edellon@med.unc.edu.
Papers in Europe PMC - 02Jensen ET7 papers · 2026
Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, NC, USA; Center for Gastrointestinal Biology and Disease, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Papers in Europe PMC - 03Savarino EV7 papers · 2026
Gastroenterology Unit, Azienda Ospedale Università of Padua, Via Giustiniani 2, 35128 Padua, Italy.
Papers in Europe PMC - 04Anderson C6 papers · 2026
Center for Gastrointestinal Biology and Disease, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Papers in Europe PMC - 05Hiremath G6 papers · 2025
Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, TN, USA.
Papers in Europe PMC - 06
- 07Dai X5 papers · 2025
Center for Gastrointestinal Biology and Disease, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Papers in Europe PMC - 08Di Sabatino A5 papers · 2026
University of Pavia, Pavia, Italy. a.disabatino@smatteo.pv.it.
Papers in Europe PMC - 09Gonsalves N5 papers · 2025
Division of Gastroenterology & Hepatology, Northwestern University - Feinberg School of Medicine, Chicago, IL, USA.
Papers in Europe PMC - 10
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name. 7 observational studies did — shown below because natural-history and cohort work can be an important step toward a trial. 1,275 trials are registered for colitis, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
low confidence · 36.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
1,275 interventional trials matched colitis, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: colitis
1,275
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT06588855·RECRUITING·A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Conditions: Moderately to Severely Active Ulcerative Colitis·Matched via name phrase
- NCT07692165·RECRUITING·A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis
Conditions: Ulcerative Colitis (UC)·Matched via name phrase
- NCT04038619·RECRUITING·Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
Conditions: Colitis · Diarrhea · Malignant Genitourinary System Neoplasm · Melanoma·Matched via name phrase
- NCT07416383·NOT YET RECRUITING·Safety and Efficiency of the Universal CNK-UT009 in Difficult-to-treat Inflammatory Bowel Disease Patients
Conditions: Inflamatory Bowel Disease · Crohn Disease (CD) · Ulcerative Colitis (UC)·Matched via name phrase
- NCT06624579·NOT YET RECRUITING·Prognostic Value of Confocal Endomicroscopy in Ulcerative Colitis: the CONF-UC Study
Conditions: Ulcerative Colitis·Matched via name phrase
- NCT07216014·RECRUITING·Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety
Conditions: Crohn's Disease and Ulcerative Colitis·Matched via name phrase
- NCT06576700·RECRUITING·Effect of Procyanidins in Leaky Gut Repairing in IBD
Conditions: Ulcerative Colitis in Remission·Matched via name phrase
- NCT05652621·RECRUITING·Efficacy of Probiotics in Patients With IBD
Conditions: Ulcerative Colitis · Irritable Bowel Syndrome·Matched via name phrase
- NCT07089771·NOT YET RECRUITING·Virtual Versus Dye-based Chromoendoscopy in Inflammatory Bowel Disease Surveillance Colonoscopy
Conditions: Inflammatory Bowel Disease (IBD) · Ulcerative Colitis (Disorder) · Crohns Disease · Colorectal Neoplasms·Matched via name phrase
- NCT07646223·NOT YET RECRUITING·Vancomycin Efficacy in Response to Dysbiosis in Atypical Colitis
Conditions: Ulcerative Colitis (UC) · Primary Sclerosing Cholangitis (PSC) · Pediatric Inflammatory Bowel Diseases·Matched via name phrase
- NCT05202990·NOT YET RECRUITING·Oral Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis
Conditions: Pediatric Ulcerative Colitis in Remission·Matched via name phrase
- NCT07177118·NOT YET RECRUITING·Risankizumab for Fibrostenotic Crohn's Disease Treatment
Conditions: Crohn Disease · Crohn Disease and Ulcerative Colitis·Matched via name phrase
- NCT04183608·RECRUITING·A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab
Conditions: Ulcerative Colitis·Matched via name phrase
- NCT07295834·NOT YET RECRUITING·Modafinil For Fatigue in IBD: A Feasibility Randomised Controlled Trial
Conditions: Crohn Disease (CD) · Ulcerative Colitis (UC) · Fatigue·Matched via name phrase
- NCT07520461·NOT YET RECRUITING·Microbiome-targeted Diet Therapy in Ulcerative Colitis
Conditions: Ulcerative Colitis·Matched via name phrase
Observational and natural-history studies
7 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT02523118·RECRUITING·OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
Conditions: Eosinophilic Gastrointestinal Disorders (EGIDs) · Eosinophilic Esophagitis · Eosinophilic Gastritis · Eosinophilic Gastroenteritis·Matched via name phrase
- NCT05199532·RECRUITING·Eosinophilic Gastrointestinal Disorders Registry
Conditions: Eosinophilic Esophagitis · Eosinophilic Gastroenteritis · Eosinophilic Colitis · Eosinophilic Gastrointestinal Disease·Matched via name phrase
- NCT05219903·RECRUITING·National, Multicenter, Retrospective, Prospective Study to Evaluate Pediatric Gastrointestinal Eosinophilic Disorders
Conditions: Eosinophilic Gastrointestinal Disorders · Eosinophilic Esophagitis · Eosinophilic Gastritis or Gastroenteritis · Eosinophilic Colitis·Matched via name phrase
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Eosinophilic colitis"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Eosinophilic colitis"
Study-type breakdown: 0 interventional · 7 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"colitis"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (1108) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity
Ingested 2026-07-27T15:31:00.925Z
